OCD Clinical Trial
Official title:
Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD
Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women during different phases in their menstrual cycle to determine the effects of hormones on the fear extinction network and on their OCD symptoms.
This study involves neuroimaging and a brief EX/RP protocol. The investigators will recruit both male and female participants. All participants will complete neuroimaging, hormonal assays and symptom ratings before and after a brief course of EX/RP. Female participants will be randomized to complete brief EX/RP during distinct phases of their menstrual cycles. This design will allow the investigators to study the effects of hormonal variation during the menstrual cycle and sex on the fear extinction network and on EX/RP outcome. The long-term goal is to optimize EX/RP for individuals suffering from OCD. Men will also be recruited for this study to further explore biological sex differences. The results will elucidate treatment mechanisms and could lead to personalized treatment recommendations for women with OCD. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00215137 -
Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT06050369 -
Objective Characterizatoion of Repetitive Behaviors
|
N/A | |
Recruiting |
NCT06347978 -
Personalized DBS for OCD Guided by Stereoencephalography Mapping
|
N/A | |
Withdrawn |
NCT03926546 -
Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT05712057 -
Neurostimulation Versus Therapy for Problems With Emotions
|
N/A | |
Not yet recruiting |
NCT03313622 -
Locating Biomarkers in OCD Through Behavioral Tasks
|
||
Withdrawn |
NCT03842345 -
DELPhI Evaluation of Psychiatric Conditions
|
||
Completed |
NCT02866422 -
Development of an Instrument That Monitors Behaviors Associated With OCD
|
N/A | |
Completed |
NCT01833442 -
Randomized Controlled Meditation Trial for Treating OCD
|
N/A | |
Recruiting |
NCT04904952 -
Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients
|
N/A | |
Completed |
NCT05981690 -
Therapist Guided, Parent-led, Cognitive Behavioural Therapy (CBT) for Preadolescent Children With Obsessive Compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT02500888 -
Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT06244121 -
Effect of Pyridoxine as Add-on Therapy in OCD Patients
|
N/A | |
Recruiting |
NCT05580614 -
Paired tVNS With ERP in OCD
|
N/A | |
Active, not recruiting |
NCT03511534 -
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT05624528 -
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT05881356 -
Discovering Factors in the Clinical Study Journey of Patients With OCD
|
||
Recruiting |
NCT03459456 -
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
|
||
Active, not recruiting |
NCT05930912 -
Psychiatric Orders in Psychoanalytic Treatment of ASD
|